2018 annual financial data
Chemomab Therapeutics 2018 Operating cash flow
Direct answer
Operating cash flow was -14,176,786 USD.
Operating income was 12,658,000 USD and net income was 13,279,000 USD.
Operating cash flow was -14,176,786 USD.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- 12,658,000 USD
- Net income
- 13,279,000 USD
- Operating cash flow
- -14,176,786 USD